- Home
- COEP vs SAG Comparison
COEP vs SAG Comparison
Compare COEP & SAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- SAG
- Stock Information
- Founded
- COEP 2017
- SAG 1975
- Country
- COEP United States
- SAG Singapore
- Employees
- COEP 7
- SAG N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- SAG
- Sector
- COEP Health Care
- SAG
- Exchange
- COEP Nasdaq
- SAG NYSE
- Market Cap
- COEP 22.3M
- SAG 26.6M
- IPO Year
- COEP N/A
- SAG 2024
- Fundamental
- Price
- COEP $9.27
- SAG $2.62
- Analyst Decision
- COEP
- SAG
- Analyst Count
- COEP 0
- SAG 0
- Target Price
- COEP N/A
- SAG N/A
- AVG Volume (30 Days)
- COEP 1.0M
- SAG 95.0K
- Earning Date
- COEP 11-13-2024
- SAG 12-19-2024
- Dividend Yield
- COEP N/A
- SAG N/A
- EPS Growth
- COEP N/A
- SAG N/A
- EPS
- COEP N/A
- SAG 0.21
- Revenue
- COEP N/A
- SAG $56,387,000.00
- Revenue This Year
- COEP N/A
- SAG N/A
- Revenue Next Year
- COEP N/A
- SAG N/A
- P/E Ratio
- COEP N/A
- SAG $12.58
- Revenue Growth
- COEP N/A
- SAG N/A
- 52 Week Low
- COEP $2.31
- SAG $2.25
- 52 Week High
- COEP $13.58
- SAG $8.27
- Technical
- Relative Strength Index (RSI)
- COEP 75.88
- SAG N/A
- Support Level
- COEP $6.22
- SAG N/A
- Resistance Level
- COEP $10.00
- SAG N/A
- Average True Range (ATR)
- COEP 1.79
- SAG 0.00
- MACD
- COEP 0.43
- SAG 0.00
- Stochastic Oscillator
- COEP 90.51
- SAG 0.00
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About SAG SAG HOLDINGS LTD
SAG Holdings Ltd engages in the business of distributing automotive and industrial spare parts with operations primarily based in Singapore, and global sales primarily generated from the Middle East and Malaysia. Its business is comprised of On-Highway Business serving the automotive sector and Off-Highway Business primarily servicing the marine, energy, mining, construction, agriculture, and oil and gas sectors. The On-Highway Business Segment supply genuine and aftermarket spare parts to customers through our Autozone retail outlets located in Singapore, as well as Malaysia. The Off-Highway Business Segment supply a wide range of components and spare parts for internal combustion engines with a strong focus on filtration products through Filtec.